AnaptysBio, Inc.ANAB stock score: 69/100

$47.40 · +0.72% · Scored Nov 19, 2026

Technical
55
Fundamental
72
News
55

The reading

AnaptysBio (ANAB) scores 69 out of 100, which reads bullish, higher than 96% of Healthcare stocks and 97% of the 4,118 US stocks we score.

The composite weights fundamentals 80% and technicals 20%: fundamentals read 72, technicals 55.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while EV/EBITDA at 0 weighs the most against it.

On the daily chart, trend-following indicators average 48 and contrarian oscillators 58.

News sentiment is neutral at 55; it is shown, not counted in the composite.

Since Aug 22, 2026 the composite has ranged from 51 to 71, and it is up 14 points over the period.

About AnaptysBio

AnaptysBio (ANAB), also known as Anaptys, is a royalty company that holds financial interests in medicines developed by larger drug makers. It was formerly an antibody research company, but it spun off its drug development operations into a separate company, First Tracks Biotherapeutics, and kept the royalty assets. Its main asset is its share of sales of Jemperli, a PD-1 cancer immunotherapy marketed by GSK and used mainly in endometrial cancer, from which Anaptys receives tiered royalties and milestone payments that rise as annual sales grow. It also holds economics in imsidolimab, an antibody for generalized pustular psoriasis that it licensed to Vanda Pharmaceuticals. Because its revenue comes almost entirely from these agreements, its results track the commercial performance of partner products rather than its own sales efforts.

Jemperli competes with other PD-1 and PD-L1 drugs, including Merck’s Keytruda and Bristol Myers Squibb’s Opdivo, while Anaptys competes for investor capital with royalty holders such as Royalty Pharma and Ligand. Its edge rests on a royalty stream with rising rates at higher sales levels and a lean cost structure after the separation. Investors who follow ANAB stock tend to watch Jemperli sales reported by GSK and new approvals that widen its use. The company’s legal dispute with GSK over the collaboration is closely followed. Imsidolimab’s progress, capital returns to shareholders and any new royalty acquisitions are other factors.

What’s driving the score

The strongest and weakest of the scorers that count toward ANAB’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

72

Pulling it up

  • Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price target score compares the current stock price to analyst consensus targets.

  • Current assets divided by current liabilities: the ability to pay short-term bills.

Holding it back

  • EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.

  • Price-to-Sales ratio compares market capitalization to annual revenue.

  • Price-to-Book ratio compares market value to book value.

36 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

48

Pulling it up

  • The price change over the last 52 weeks.

  • Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

Holding it back

  • Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.

  • Where the close sits against its 100-day SMA.

  • Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
55

Technical score by timeframe

ChartScoreWeight
Hourly561
Daily483
Weekly542
Monthly672

Composite score, last 90 days

05010069Aug 22, 2026Nov 19, 2026Aug 22, 2026: 55Aug 23, 2026: 55Aug 24, 2026: 54Aug 25, 2026: 56Aug 26, 2026: 55Aug 27, 2026: 55Aug 28, 2026: 53Aug 29, 2026: 53Aug 30, 2026: 52Aug 31, 2026: 53Sep 1, 2026: 53Sep 2, 2026: 54Sep 3, 2026: 56Sep 4, 2026: 55Sep 5, 2026: 54Sep 6, 2026: 54Sep 7, 2026: 54Sep 8, 2026: 55Sep 9, 2026: 52Sep 10, 2026: 51Sep 11, 2026: 51Sep 12, 2026: 51Sep 13, 2026: 51Sep 14, 2026: 51Sep 15, 2026: 52Sep 16, 2026: 52Sep 17, 2026: 53Sep 18, 2026: 53Sep 19, 2026: 53Sep 20, 2026: 53Sep 21, 2026: 55Sep 22, 2026: 53Sep 23, 2026: 56Sep 24, 2026: 56Sep 25, 2026: 55Sep 26, 2026: 55Sep 27, 2026: 55Sep 28, 2026: 66Sep 29, 2026: 66Sep 30, 2026: 66Oct 1, 2026: 64Oct 2, 2026: 65Oct 3, 2026: 65Oct 4, 2026: 65Oct 5, 2026: 66Oct 6, 2026: 65Oct 7, 2026: 63Oct 8, 2026: 64Oct 9, 2026: 64Oct 10, 2026: 64Oct 11, 2026: 64Oct 12, 2026: 65Oct 13, 2026: 64Oct 14, 2026: 65Oct 15, 2026: 67Oct 16, 2026: 65Oct 17, 2026: 65Oct 18, 2026: 65Oct 19, 2026: 67Oct 20, 2026: 64Oct 21, 2026: 66Oct 22, 2026: 66Oct 23, 2026: 66Oct 24, 2026: 66Oct 25, 2026: 66Oct 26, 2026: 67Oct 27, 2026: 67Oct 28, 2026: 68Oct 29, 2026: 66Oct 30, 2026: 65Oct 31, 2026: 65Nov 1, 2026: 65Nov 2, 2026: 65Nov 3, 2026: 66Nov 4, 2026: 65Nov 5, 2026: 63Nov 6, 2026: 63Nov 7, 2026: 63Nov 8, 2026: 63Nov 10, 2026: 67Nov 11, 2026: 68Nov 12, 2026: 71Nov 13, 2026: 66Nov 14, 2026: 66Nov 15, 2026: 67Nov 16, 2026: 66Nov 17, 2026: 67Nov 18, 2026: 68Nov 19, 2026: 69
Show the daily numbers
DateComposite
Nov 19, 202669
Nov 18, 202668
Nov 17, 202667
Nov 16, 202666
Nov 15, 202667
Nov 14, 202666
Nov 13, 202666
Nov 12, 202671
Nov 11, 202668
Nov 10, 202667
Nov 8, 202663
Nov 7, 202663
Nov 6, 202663
Nov 5, 202663
Nov 4, 202665
Nov 3, 202666
Nov 2, 202665
Nov 1, 202665
Oct 31, 202665
Oct 30, 202665
Oct 29, 202666
Oct 28, 202668
Oct 27, 202667
Oct 26, 202667
Oct 25, 202666
Oct 24, 202666
Oct 23, 202666
Oct 22, 202666
Oct 21, 202666
Oct 20, 202664
Oct 19, 202667
Oct 18, 202665
Oct 17, 202665
Oct 16, 202665
Oct 15, 202667
Oct 14, 202665
Oct 13, 202664
Oct 12, 202665
Oct 11, 202664
Oct 10, 202664
Oct 9, 202664
Oct 8, 202664
Oct 7, 202663
Oct 6, 202665
Oct 5, 202666
Oct 4, 202665
Oct 3, 202665
Oct 2, 202665
Oct 1, 202664
Sep 30, 202666
Sep 29, 202666
Sep 28, 202666
Sep 27, 202655
Sep 26, 202655
Sep 25, 202655
Sep 24, 202656
Sep 23, 202656
Sep 22, 202653
Sep 21, 202655
Sep 20, 202653
Sep 19, 202653
Sep 18, 202653
Sep 17, 202653
Sep 16, 202652
Sep 15, 202652
Sep 14, 202651
Sep 13, 202651
Sep 12, 202651
Sep 11, 202651
Sep 10, 202651
Sep 9, 202652
Sep 8, 202655
Sep 7, 202654
Sep 6, 202654
Sep 5, 202654
Sep 4, 202655
Sep 3, 202656
Sep 2, 202654
Sep 1, 202653
Aug 31, 202653
Aug 30, 202652
Aug 29, 202653
Aug 28, 202653
Aug 27, 202655
Aug 26, 202655
Aug 25, 202656
Aug 24, 202654
Aug 23, 202655
Aug 22, 202655

Key facts

Market cap
$1.4B
Sector
Healthcare
Industry
Biotechnology
Beta
0.37
Risk grade (1–10)
7
Next earnings
Nov 12, 2026

Questions

What is ANAB's stock rating today?

ANAB scores 69/100 (Bullish) as of Nov 19, 2026: technical 55, fundamental 72, and news sentiment 55, which is shown but not counted. Scores are recomputed every night.

What does AnaptysBio do?

AnaptysBio (ANAB), also known as Anaptys, is a royalty company that holds financial interests in medicines developed by larger drug makers. It was formerly an antibody research company, but it spun off its drug development operations into a separate company, First Tracks Biotherapeutics, and kept the royalty assets.

Is ANAB stock a buy?

The score is not a buy or sell recommendation. A 69 says the technical and fundamental signals we measure lean bullish today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the ANAB score calculated?

98 weighted scorers feed it today: 36 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 4 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.

Embed this score

A badge for a blog post, newsletter or README. It updates every night and links back here. More badges

ANAB stock score

HTML

<a href="https://stocksscores.com/stocks/anab/"><img src="https://stocksscores.com/stocks/anab/badge.svg" alt="ANAB stock score" height="20"></a>

Markdown

[![ANAB stock score](https://stocksscores.com/stocks/anab/badge.svg)](https://stocksscores.com/stocks/anab/)